Stay updated on Emixustat in Stargardt Macular Atrophy Clinical Trial
Sign up to get notified when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.

Latest updates to the Emixustat in Stargardt Macular Atrophy Clinical Trial page
- Check3 days agoChange DetectedThe page adds a dedicated Locations section with Texas listed as a site. The older Texas Locations entry has been removed and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.2 is shown instead of v3.3.1; no other visible changes to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedA new note clarifies that publications are auto-filled from PubMed and may not be about the study, and the page revision was updated to v3.3.1. The previous PubMed note and earlier revision label (v3.2.0) were removed.SummaryDifference0.1%

- Check40 days agoChange DetectedA government funding/operating status notice was removed from the page; the study details content itself remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedThe new screenshot shows minor layout adjustments and updated timestamps, while the study details, eligibility criteria, locations, enrollment, and primary/secondary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

Stay in the know with updates to Emixustat in Stargardt Macular Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.